Five-year quality of life in patients with high-risk localized prostate cancer treated with external beam radiotherapy alone versus external beam radiotherapy with high-dose-rate brachytherapy boost: a prospective multicenter study

CONCLUSIONS: After five years of follow-up, EBRT alone or combined with HDR-BT boost had a similar impact on HRQL in patients with high-risk localized PCa. However, patients in the EBRT alone group experienced greater worsening of hormonal domain according to EPIC questionnaire.PMID:34025730 | PMC:PMC8117716 | DOI:10.5114/jcb.2021.103580

Source: Journal of Contemporary Brachytherapy - May 24, 2021 Category: Cancer & Oncology Authors: Evelyn Mart ínez Olatz Garin Yolanda Pardo Pablo Fern ández Benjamin Guix Cristina Guti érrez Ana Boladeras Ferran Ferrer Tania Hern ández Adriana Ayala Mikel Egiguren Gema Fern ández V íctor Muñoz V íctor Macías Joan Pera Àngels Pont Montserrat Source Type: research